摘要
目的:分析开心散60%乙醇提取物(KXS-60%E)体外各成分的归属来源及大鼠灌服KXS-60%E后药物入血成分。方法:应用UPLC-TOF-MS技术建立KXS-60%E体外成分以及大鼠灌服药物后含药血清样品的分析方法,根据各单味药的色谱峰确定全方主要成分的来源归属;对比空白血清、含药血清的成分异同,分析药物的入血成分。结果:通过对比KXS-60%E与各单味药的正负总离子流图,归属了94个主要色谱峰的来源;大鼠口服KXS-60%E后,在血中分析指定了41个入血成分,其中13个为新产生的代谢产物,28个成分为KXS-60%E的原形成分。结论:血中移行成分及其代谢产物是KXS-60%E防治老年性痴呆(AD)的更直接药效物质基础,对其进行深入的研究将有助于阐明开心散防治AD的作用机制。
Objective:To analyse the origin of peaks in Kaixinsan (KXS) extracted by 60% ethano (KXS-60% E) Ⅰ and the constituents in rat plasma after oral administration-of KXS-60% E.Method:A UPLC-TOF-MS method for analyzing the constituents in KXS-60% E and in rat plasma after oral administration of KXS-60% E,has been established.The origin of peaks in KXS-60% E were pointed out compared with each single herb in the formula similarly,the origin of peaks in treated serum after oral KXS-60% E were identified by contrasting the control rat serum.Result:Ninty-four compounds were detected in KXS-60% E in vitro,by compare with control rat plasma,41 peaks were pointed out in treated plasma.Concluding 28 original form in KXS-60% E and 13 metabolites.Conclusion:The constituents absorbed into blood and their metabolites of KXS-60% E were the direct basis of action of the drug,further study on these constituents may clarify the mechanism of KXS prevention and treatment on Alzhemer's disease.
出处
《中国实验方剂学杂志》
CAS
北大核心
2014年第6期179-183,共5页
Chinese Journal of Experimental Traditional Medical Formulae
基金
国家自然科学基金青年基金项目(81303248)
黑龙江省教育厅海外学人科研项目(1153h18)
黑龙江省科技厅面上项目(LC2008C264)
哈尔滨市科技局科技创新人才研究专项基金项目(2013RFQXJ154)
黑龙江中医药大学科研基金面上项目(2010)